Treatment of peritoneal carcinomatosis due to GI-tract cancer by intraperitoneal application of the trifunctional antibody catumaxomab (anti-EpcAM x anti-CD3): Results of a phase VII trial.
Journal title abbreviation:
J Clin Oncol
Year:
2005
Journal volume:
23
Journal issue:
16
Pages contribution:
173S-173S
Language:
eng
Print-ISSN:
0732-183X
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)